Cystic fibrosis (CF) is an autosomal ... and bronchiectasis with resulting marked decline in pulmonary function. The only treatment for end-stage CF lung disease is lung transplantation.
This was supported by comparing their molecular characteristics to samples from patients who had end-stage pulmonary fibrosis ...
Identifying the underlying causes of prolonged lung inflammation associated with radiographic abnormalities could be key understanding long COVID and other lung conditions, researchers say.
PPF is identified by decline in lung function, worsening symptoms, and increased fibrosis on imaging ... of the experiences of people with end-stage interstitial lung disease and their family ...
In a small Phase IIa trial, Insilico’s generative AI-designed idiopathic pulmonary fibrosis drug improved lung function and ...
Idiopathic pulmonary fibrosis (IPF ... membrane oxygenation as a bridge to transplant has enabled more end-stage patients to survive to transplant. The number of transplantable organs is also ...
The Program for Pulmonary Fibrosis and Interstitial Lung Disease's mission is to provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD). The University of ...
Boehringer Ingelheim is seeking regulatory approval for nerandomilast after a Phase III trial in idiopathic pulmonary ...
Into the lungs, the windpipe is further branched to tubes called bronchioles that end in small sacs called ... In majority of the cases, Pulmonary Fibrosis is seen in people who have existing ...
Met primary objective demonstrating nintedanib DPI was safe and well toleratedParticipants did not experience adverse events typically reported ...
Agomab Therapeutics NV (‘Agomab’) today announced a $89 million (€82.1 million) Series D financing round, with participation from new investors Sanofi ...
Dyspnea is often a clinical feature of progressive CF lung disease and is more prevalent during pulmonary exacerbations ... in an adolescent patient with end-stage CF who experienced acute ...